Search

Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects

Journal: Current Pharmaceutical Biotechnology
Volume: 15 Issue: 7 Year: 2014 Page: 609-619
Author(s): Francisca Araujo,Neha Shrestha,Pedro L. Granja,Jouni Hirvonen,Hélder A. Santos,Bruno Sarmento

Physical Activity, Insulin Action, and Diabetes Prevention and Control

Journal: Current Diabetes Reviews
Volume: 3 Issue: 3 Year: 2007 Page: 176-184
Author(s): Sheri R. Colberg

Expression and Purification of Exendin-4 Dimer in Escherichia coli and Its Interaction with GLP-1 Receptor In Vitro

Journal: Protein & Peptide Letters
Volume: 13 Issue: 8 Year: 2006 Page: 823-827
Author(s): Lina Yi, Xiaopu Yin, Dongzhi Wei, Yushu Ma

Expression and Purification of Optimized rolGLP-1, A Novel GLP-1 Analog, in Escherichia Coli BL21(DE3) and its Good Glucoregulatory Effect on Type 2 Diabetic Mice

Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 11 Year: 2013 Page: 985-994
Author(s): Baicheng Ma,Peipei Tu,Xingyu Zhao,Yaofang Zhang,Yu Wang,Chao Ma,Yanli Ji,Xiaodan Li,Syed A. Abbas,Minggang Li

Alogliptin: a Novel Molecule for Improving Glycemic Control in Type II Diabetes Mellitus

Journal: Current Diabetes Reviews
Volume: 6 Issue: 6 Year: 2010 Page: 410-421
Author(s): Somsuvra B. Ghatak, Devang S. Patel, Neeraj Shanker, Ambrish Srivastava, Shrikalp S. Deshpand, Shital J. Panchal

Glucagon Like Peptides-1 Modulators as Newer Target for Diabetes

Journal: Current Drug Targets
Volume: 9 Issue: 1 Year: 2008 Page: 911-920
Author(s): H. B. Vaidya, R. K. Goyal

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 8 Issue: 4 Year: 2008 Page: 317-324
Author(s): Jonathan D. Roth, Christine M. Mack, Christopher J. Soares, Soumitra S. Ghosh, David G. Parkes

Investigation of Exenatide Elimination and Its In Vivo and In Vitro Degradation

Journal: Current Drug Metabolism
Volume: 7 Issue: 4 Year: 2006 Page: 367-374
Author(s): Kathrin Copley, Kevin McCowen, Richard Hiles, Loretta L. Nielsen, Andrew Young, David G. Parkes

Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors

Journal: Current Diabetes Reviews
Volume: 4 Issue: 2 Year: 2008 Page: 101-109
Author(s): Anthony Stonehouse, Ted Okerson, David Kendall, David Maggs

Dipeptidyl Peptidase IV Inhibitors: The Next Generation of New Promising Therapies for the Management of Type 2 Diabetes

Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 547-555
Author(s): Elena Sebokova, Andreas D. Christ, Markus Boehringer, Jacques Mizrahi